Providence Hospital Cancer Center is a clinical research site located in Southfield, Michigan, United States 48075.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Providence Hospital Cancer Center has participated in 5 clinical trials.
Therapeutic areas: Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma.
Sponsors: Vical, Providence Hospital, Maxim Pharmaceuticals.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Providence Hospital Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence Hospital Cancer Center has 5 clinical trials on record. Their work covers Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma.
Yes — Providence Hospital Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.